Skip to search formSkip to main contentSkip to account menu

gatifloxacin

Known as: Gatifloxacino, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 
A synthetic 8-methoxyfluoroquinolone with antibacterial activity against a wide range of gram-negative and gram-positive microorganisms. Gatifloxacin… 
National Institutes of Health

Related topics

Related topics

36 relations

Narrower (4)

AM 1155BMS-206584TequinZymar
AmiodaroneAmiodarone hydrochlorideBacterial InfectionsBronchitis

Broader (3)

Anti-Bacterial AgentsFluoroquinolonesTopoisomerase II Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Square pyramidal copper(II) complexes with forth generation fluoroquinolone and neutral bidentate ligand: structure, antibacterial, SOD mimic and DNA-interaction studies.
Highly Cited
2007
Highly Cited
2007
Synthesis and antibacterial activity of 4,5,6,7-tetrahydro-thieno[3,2-c]pyridine quinolones.
Highly Cited
2006
Highly Cited
2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
2006
2006
The formation of an antibacterial agent-apatite composite coating on a polymer surface using a metastable calcium phosphate solution.
2006
2006
Hydrophilic acrylic intraocular lens as a drug‐delivery system for fourth‐generation fluoroquinolones
Review
2006
Review
2006
In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
2004
2004
In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.
2004
2004
Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.
Highly Cited
2003
Highly Cited
2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction.
OBJECTIVES Recently, anecdotal reports via the FDA's MedWatch reporting system have documented rare but serious hyperglycaemia in… 
2002
2002
Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria
ABSTRACT By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)